Related Experiment Video
Updated: Nov 26, 2025

05:49
Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders
Published on: November 1, 2024
1.1K
How does the brain change in chronic migraine? Developing disease biomarkers
Patricia Pozo-Rosich1,2, Gianluca Coppola3, Julio Pascual4
1Headache Unit, Neurology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Cephalalgia : an International Journal of Headache
|December 9, 2020
Summary
Validated chronic migraine biomarkers are emerging from imaging and neurophysiological studies. These biomarkers show promise for diagnosis, prognosis, and personalized treatment, moving towards precision medicine in migraine care.
Area of Science:
- Neurology
- Biomarker Discovery
- Migraine Pathophysiology
Background:
- Chronic migraine diagnosis and prognosis can be improved with validated biomarkers.
- Understanding migraine pathophysiology is crucial for developing effective treatments.
Purpose of the Study:
- To review and interpret the current literature on chronic migraine biomarker development.
- To assess the potential of existing data for biomarker creation.
Main Methods:
- Review of functional and structural imaging studies.
- Analysis of neurophysiological and biochemical research.
- Interpretation of data related to chronic migraine progression.
Main Results:
- Brain structure, function, evoked potentials, and neuropeptide concentrations show promise as biomarkers.
- Biomarkers could aid in classification, prognosis, and treatment response prediction.
- Further optimization and validation of identified biomarkers are necessary.
Conclusions:
- Imaging, neurophysiological, and biochemical changes can inform biomarker development.
- Validated biomarkers will facilitate diagnosis, prognosis, and personalized migraine therapy.
- Advancement in biomarker research supports the practice of precision medicine for improved patient care.

